Literature DB >> 11752579

KLF6, a candidate tumor suppressor gene mutated in prostate cancer.

G Narla1, K E Heath, H L Reeves, D Li, L E Giono, A C Kimmelman, M J Glucksman, J Narla, F J Eng, A M Chan, A C Ferrari, J A Martignetti, S L Friedman.   

Abstract

Kruppel-like factor 6 (KLF6) is a zinc finger transcription factor of unknown function. Here, we show that the KLF6 gene is mutated in a subset of human prostate cancer. Loss-of-heterozygosity analysis revealed that one KLF6 allele is deleted in 77% (17 of 22) of primary prostate tumors. Sequence analysis of the retained KLF6 allele revealed mutations in 71% of these tumors. Functional studies confirm that whereas wild-type KLF6 up-regulates p21 (WAF1/CIP1) in a p53-independent manner and significantly reduces cell proliferation, tumor-derived KLF6 mutants do not. Our data suggest that KLF6 is a tumor suppressor gene involved in human prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11752579     DOI: 10.1126/science.1066326

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  161 in total

Review 1.  Krüppel cripples prostate cancer: KLF6 progress and prospects.

Authors:  Goutham Narla; Scott L Friedman; John A Martignetti
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

2.  Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain.

Authors:  Saku Miyamoto; Toru Suzuki; Shinsuke Muto; Kenichi Aizawa; Akatsuki Kimura; Yoshiko Mizuno; Tomoko Nagino; Yasushi Imai; Naruhiko Adachi; Masami Horikoshi; Ryozo Nagai
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  Klf6/copeb is required for hepatic outgrowth in zebrafish and for hepatocyte specification in mouse ES cells.

Authors:  Xiao Zhao; Christopher Monson; Chuan Gao; Valerie Gouon-Evans; Nobuyuki Matsumoto; Kirsten C Sadler; Scott L Friedman
Journal:  Dev Biol       Date:  2010-04-27       Impact factor: 3.582

Review 4.  Role of Kruppel-like factors in leukocyte development, function, and disease.

Authors:  Zhuoxiao Cao; Xinghui Sun; Basak Icli; Akm Khyrul Wara; Mark W Feinberg
Journal:  Blood       Date:  2010-07-08       Impact factor: 22.113

5.  Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene.

Authors:  Mario R Calderon; Mark Verway; Beum-Soo An; Analisa DiFeo; Tarek A Bismar; David K Ann; John A Martignetti; Tali Shalom-Barak; John H White
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

6.  Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.

Authors:  Xiu-cheng Pan; Zhi Chen; Feng Chen; Xiao-hong Chen; Han-yin Jin; Xiao-yan Xu
Journal:  J Zhejiang Univ Sci B       Date:  2006-10       Impact factor: 3.066

7.  Canonical and non-canonical aryl hydrocarbon receptor signaling pathways.

Authors:  Eric J Wright; Karen Pereira De Castro; Aditya D Joshi; Cornelis J Elferink
Journal:  Curr Opin Toxicol       Date:  2017-01-18

8.  Effects of Kruppel-like factor 6 on osteosarcoma cell biological behavior.

Authors:  Zhu Jianwei; Bai Enzhong; Liu Fan; Liu Jian; An Ning
Journal:  Tumour Biol       Date:  2013-01-16

9.  TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction.

Authors:  Luisa M Botella; Francisco Sanz-Rodriguez; Yusuke Komi; Africa Fernandez-L; Elisa Varela; Eva M Garrido-Martin; Goutham Narla; Scott L Friedman; Soichi Kojima
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

10.  Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression.

Authors:  Daniel P Jackson; Hui Li; Kristen A Mitchell; Aditya D Joshi; Cornelis J Elferink
Journal:  Mol Pharmacol       Date:  2014-01-15       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.